Medical decompressive therapy for primary and metastatic intracranial tumours

Lancet Neurology

Volumn 2, Issue 6, 2003, Pages 357-365

  Sarin, Rajiv ^a   Murthy, Vedang ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARMUSTINE; CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTOTOXIC AGENT; DEXAMETHASONE; FUROSEMIDE; GEMCITABINE; GLYCEROL; MANNITOL; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ANXIETY DISORDER; BRAIN EDEMA; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CUSHINGOID SYNDROME; DECOMPRESSION; DEPRESSION; DIGESTIVE SYSTEM PERFORATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; EVIDENCE BASED MEDICINE; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERGLYCEMIA; INFECTION; INSOMNIA; INTRACRANIAL PRESSURE; INTRACRANIAL TUMOR; IRRADIATION; IRRITABILITY; LETHARGY; LONG TERM CARE; MANIA; MENTAL FUNCTION; MYOPATHY; NEUROLOGIC DISEASE; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PSYCHOSIS; REVIEW; SEIZURE; SIDE EFFECT; SYMPTOM; TOXICITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VOMITING; WITHDRAWAL SYNDROME;

ADRENAL CORTEX HORMONES; ANTICONVULSANTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; HUMANS; INTRACRANIAL PRESSURE; NEOPLASM METASTASIS;

EID: 1542505709     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00410-1     Document Type: Review

References (93)

1. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics 2000. CA Cancer J Clin. 50:2000;7-33.
2. Wen P.Y., Black P.M., Loeffler J.S. Treatment of metastatic cancer. DeVita V.T. Jr. Cancer: principles and practice of oncology. 2000;2655-2670 Lippincott Williams & Wilkins, Philadelphia.
3. Walker A.E., Robins M., Weinfeld F.D. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology. 35:1985;219-226.
4. Pickren J.W., Lopez G., Tsukada Y., et al. Brain metastasis: an autopsy study. Cancer Treat Symp. 2:1983;295-313.
5. Weissman D.E. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol. 6:1988;543-551.
6. Alderson P., Roberts I. Corticosteroids for acute traumatic brain injury (Cochrane Review). The Cochrane Library, Issue 4. 2000;Update Software, Oxford.
7. Alderson P., Roberts I. Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ. 314:1997;1855-1859.
8. McIntyre P.B., Berkey C.S., King S.M., et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 278:1997;925-931.
9. Prasad K., Volmink J., Menon G.R. Steroids for treating tuberculous meningitis (Cochrane Review). The Cochrane Library, Issue 4. 2001;Update Software, Oxford.
10. Vecht Ch.J., Hovestadt A., Verbiest H.B.C., et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumours: a randomized study of 4, 8, and 16 mg per day. Neurology. 44:1994;675-680.
11. Wolfson A.H., Snodgrass S.M., Schwade J.G., et al. The role of steroids in the management of metastatic carcinoma to the brain: a pilot prospective trial. Am J Clin Oncol. 17:1994;234-238.
12. Horton J., Baxter D.H., Olson K.B. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med. 111:1971;334-336.
13. Hensley M.L., Schuchter L.M., Lindley C., et al. American Society of Clinical Oncology Clinical Practice Guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 17:1999;3333-3335.
14. Kofman S., Garvin J.S., Nagamani D., et al. Treatment of cerebral metastasis from breast carcinoma with prednisolone. JAMA. 163:1957;1473-1476.
15. Posner J.B. Neurological complications of cancer. 1995;FA Davis, 1995, Philadelphia.
16. Van Roost D., Hartmann A., Quade G. Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients: a Xe/CT study. Acta Neurochir (Wien). 143:2001;37-43.
17. Jarden J.O., Dhawan V., Poltorak A., et al. Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb: the effect of dexamethasone and whole-brain radiation therapy. Ann Neurol. 18:1985;636-646.
18. Weinstein J.D., Frederic J.T., Marvin E.J., et al. The effect of dexamethasone on brain edema in patients with metastatic brain tumors. Neurology. 23:1973;121-129.
19. French L.A. Use of steroids in the treatment of cerebral edema. Bull NY Acad Med. 42:1966;301-311.
20. Chumas P., Condon B., Oluoch-Olunya D., et al. Early changes in peritumorous oedema and contralateral white matter after dexamethasone: a study using proton magnetic resonance spectroscopy. J Neurol Neurosurg Psychiatry. 62:1997;590-595.
21. Galicich J.H., French L.A., Melby J. Use of dexamethasone in the treatment of cerebral edema associated with brain tumours. J Lancet. 81:1961;46-53.
22. Galicich J.H., French L.A. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumours and brain surgery. Am Practit Dig Treat. 12:1961;169-174.
23. Ruderman N.B., Hall T.C. Use of glucocorticoids in the palliative treatment of metastatic brain tumours. Cancer. 18:1965;298-306.
24. Fishman R.A. Steroids in the treatment of brain edema. N Engl J Med. 306:1982;359-360.
25. Nisce L.Z., Hilaris B.S., Chu F.C. A review of experience with irradiation of brain metastasis. Am J Roentgenol Radium Ther Nucl Med. 111:1971;329-333.
26. Borgelt B., Gelber R., Kramer S., et al. Palliation of brain metastasis: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 6:1980;1-9.
27. Tarver R.D., Richmond B.D., Klatte E.C. Cerebral metastases from lung carcinoma: neurological and CT correlation: work in progress. Radiology. 153:1984;689-692.
28. Ferrigno D., Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer. Chest. 106:1994;1025-1029.
29. Salbeck R., Grau H.C., Artmann H. Cerebral tumor staging in patients with bronchial carcinoma by computed tomography. Cancer. 66:1990;2007-2011.
30. Weissman D.E., Janjan N.A., Erickson B., et al. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. J Neurooncol. 11:1991;235-239.
31. Schloss M.H., Freidberg S.R., Heatley G.J., et al. Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas. Acta Oncol. 28:1989;51-55.
32. Sahani K., Newton K.A., Philips R.H. Intracranial metastasis: treatment with steroids and radiotherapy. Indian J Cancer. 23:1986;141-145.
33. Peters W.P., Holland J.H., Senn H., et al. Corticosteroid administration and localized leukocyte mobilization in man. N Engl J Med. 282:1972;342-345.
34. Heidenreich S., Kubis T., Schmidt M., et al. Glucocorticoid induced alterations of monocyte defense mechanisms against Candida albicans. Cell Immunol. 157:1994;320-327.
35. Wen P.Y. Diagnosis and management of brain tumors. Black P.M., Loeffler J.S. Cancer of nervous system. 1997;106-127 Blackwell Science Inc, Massachusetts.
36. Gaab M.R., Trost H.A., Ancantara A., et al. Ultrahigh" dexamethasone in acute brain injury: results from a prospective randomized double-blind multicenter trial (GUDHIS). Zentralbl Neurochir. 55:1994;135-143.
37. Mercadante S., Fulfaro F., Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer. 9:2001;386-389.
38. Coia L.R., Aaronson N., Linggood R., et al. A report of the consensus workshop panel on the treatment of brain metastases. Int J Radiat Oncol Biol Phys. 23:1992;223-227.
39. Lieberman A., LeBrun Y., Glass P., et al. Use of high dose corticosteroids in patients with inoperable brain tumours. J Neurol Neurosurg Psychiatry. 40:1977;678-682.
40. Renaudin J., Fewer D., Wilson C.B., et al. Dose dependency of decadron in patients with partially excised brain tumours. J Neurosurg. 39:1973;302-305.
41. Heimdal K., Hirschberg H., Slettebo H., et al. High incidence of serious side effects of high dose dexamethasone treatment in patients with epidural spinal cord compression. J Neuro Oncol. 12:1992;141-144.
42. Weissman D.E., Dufer D., Vogel V., et al. Corticosteroid toxicity in neuro oncology patients. J Neuro Oncol. 5:1987;125-128.
43. Martenson J.A. Jr, Evans R.G., Lie M.R., et al. Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC). J Neuro Oncol. 3:1985;77-84.
44. Dropcho E.J., Soong S.J. Steroid-induced weakness in patients with primary brain tumors. Neurology. 41:1991;1235-1239.
45. Caincross J.G., Kim J.H., Posner J.B. Radiation therapy for brain metastases. Ann Neurol. 7:1980;529-541.
46. Lewis G.P., Jusko W.J., Graves L., et al. Prednisone side effects and serum-protein levels: a collaborative study. Lancet. 7728:1971;778-780.
47. Afifi A.K., Bergman R.A., Harvey J.C. Steroid myopathy: clinical, histologic and cytologic observations. Johns Hopkins Med J. 123:1968;158-177.
48. Conn H.O., Blitzer B.L. Non-association of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med. 294:1976;473-479.
49. Messer J., Reitman D., Sacks H.S., et al. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 309:1983;21-24.
50. Conn H.O., Poynard T. Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis. 38:1985;457-468.
51. Weiner H.L., Rezai A.R., Cooper P.R. Sigmoid diverticular perforation in neurosurgical patients receiving high-dose corticosteroids. Neurosurgery. 33:1993;40-43.
52. Fadul C.E., Lemann W., Thaler H.T., et al. Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology. 38:1988;348-352.
53. Dayton M.T., Kleckner S.C., Brown D.K. Peptic ulcer perforation associated with steroid use. Arch Surg. 122:1987;376-380.
54. ReMine S.G., McIlrath D.C. Bowel perforation in steroid-treated patients. Ann Surg. 192:1980;581-586.
55. Batchelor T.T., Taylor L.P., Thaler H.T., et al. Steroid myopathy in cancer patients. Neurology. 48:1997;1234-1238.
56. Hickson R.C., Davis J.R. Partial prevention of glucocorticoid-induced muscle atrophy by endurance training. Am J Physiol. 241:1981;E226-E232.
57. Hanks G.W., Trueman T., Twycross R.G. Corticosteroids in terminal cancer: a prospective survey of current practice. Postgrad Med J. 59:1983;702-706.
58. Henson J.W., Jalaj J.K., Walker R.W., et al. Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol. 48:1991;406-409.
59. Slivka A., Wen P.Y., Shea W.M., et al. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med. 94:1993;216-219.
60. Brophy T., Chalk J.B., Ridgeway K., et al. Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry. 47:1984;1081-1086.
61. Stiefel F.C., Breitbart W.S., Holland J.C. Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest. 7:1989;479-491.
62. Breitbart W., Stiefel F., Kornblith A.B., et al. Neuropsychiatric disturbance in cancer patients with epidural spinal cord compression receiving high dose corticosteroids: a prospective comparison study. Psycho-Oncology. 2:1993;233-245.
63. Vincent F.M. The neuropsychiatric complications of corticosteroid therapy. Compr Ther. 21:1995;524-528.
64. Mariotta M., Perewusnyk G., Koechli O.R., et al. Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells. Strahlenther Onkol. 175:1999;392-396.
65. Brock W.A., Williams M., McNaney D., et al. Modification by dexamethasone of radiation response of in vitro cultured cells. Int J Radiat Oncol Biol Phys. 10:1984;2113-2117.
66. Wolff J.E.A., Jurgens H. Dexamethasone induced partial resistance to methotrexate in C6-glioma cells. Anticancer Res. 14:1994;1585-1588.
67. Rieger J., Durka S., Streffer J., et al. Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol. 365:1999;301-308.
68. Benediktsson G., Blomquist E., Carlsson J. Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines. J Neuro Oncol. 8:1990;47-53.
69. Lordo C.D., Stroude E.C., Del Maestro R.F. The effects of dexamethasone on C6 astrocytoma radiosensitivity. J Neurosurg. 70:1989;767-773.
70. Tajima A., Yen M.H., Nakata H., et al. Effects of dexamethasone on blood flow and volume of perfused microvessels in traumatic brain edema. Adv Neurol. 52:1990;343-350.
71. Neuwelt E.A., Barnett P.A., Bigner D.D., et al. Effects of adrenal cortical steroids and osmotic blood-brain barrier opening of methotrexate delivery to gliomas in rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA. 79:1982;4420-4423.
72. Straathof C.S., van den Bent M.J., Ma J., et al. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. J Neurooncol. 37:1998;1-8.
73. Koehler P.J. Use of corticosteroids in neuro-oncology. Anti Cancer Drugs. 6:1995;19-33.
74. Uzal D., Ozyar E., Hayran M., et al. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Radiother Oncol. 48:1998;29-32.
75. Green S.B., Byar D.P., Walker M.D., et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 67:1983;121-132.
76. Chalk J.B., Ridgeway K., Brophy T., et al. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry. 47:1984;1087-1090.
77. Gattis W.A., May D.B. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: A case report and review. Ann Pharmacother. 30:1996;520-526.
78. Lackner T.E. Interaction of dexamethasone with phenytoin. Pharmacotherapy. 11:1991;344-347.
79. Borg M.F., Probert J.C., Zwi L.J. Is phenytoin contraindicated in patients receiving cranial irradiation? Australas-Radiol. 39:1995;42-46.
80. Delattre J.Y., Safai B., Posner J.B. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology. 38:1988;194-198.
81. Cantore G., Guidetti B., Virno B. Oral Glycerol for the reduction of intracranial pressure. J Neurosurg. 21:1964;278-283.
82. Bedikian A.Y., Valdivieso M., Heilbrun L.K., et al. Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic disease. South Med J. 73:1980;1210-1214.
83. Rottenberg D., Hurwitz B.J., Posner J.B. The effect of oral glycerol on intraventricular pressure in man. Neurology. 27:1977;600-608.
84. Frank J. Management of intracranial hypertension. Med Clin North Am. 77:1993;61-75.
85. Cruz J., Minoja G., Okuchi K. Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial. Neurosurgery. 49:2001;864-871.
86. Roberts P.A., Pollay M., Engles C., et al. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol. J Neurosurg. 66:1987;440-446.
87. Streffer J.R., Bitzer M., Schabet, et al. Response of radiochemotherapy associated cerebral edema to a phytotherapeutic agent, H15. Neurology. 56:2001;1219-1221.
88. Janssen G., Bode U., Breu H., et al. Boswellic acids in the palliative therapy of children with progressive or relapsed brain tumors. Klin Padiatr. 212:2000;189-195.
89. Priestman T.J., Dunn J., Brada M., et al. Final results of the Royal College of Radiologists' Trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol. 8:1996;308-315.
90. Sarin R., Dinshaw K.A. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol. 9:1997;272.
91. Gupta T., Sarin R. Poor prognosis high-grade glioma: Evolving an evidence based standard of care. Lancet Oncol. 3:2002;557-564.
92. Zimm S., Wampler G.L., Stablein D., et al. Intracerebral metastases in solid tumour patients: natural history and results of treatment. Cancer. 48:1981;384-391.
93. Roberts I. The CRASH trial: the first large-scale, randomised, controlled trial in head injury. Crit Care. 5:2001;292-293.